FibroGenesis Reports Breakthrough in Prevention of COVID-19 Blood Clotting
August 12, 2020 10:07 ET
|
FibroGenesis
HOUSTON, Aug. 12, 2020 (GLOBE NEWSWIRE) -- FibroGenesis, a clinical stage company developing fibroblast based therapeutic solutions for unmet medical needs, announced today new data supporting...
Cancer Stem Cells Market To Reach USD 2.18 Billion By 2027 | Reports and Data
May 14, 2020 11:06 ET
|
Reports and Data
New York, May 14, 2020 (GLOBE NEWSWIRE) -- The global Cancer Stem Cells market is forecast to reach USD 2.18 Billion by 2027, according to a new report by Reports and Data. The market for stem cells...
Stem Cell Network Warns that Claims of Stem Cell Treatments for COVID-19 Are Unfounded and Misleading
March 31, 2020 15:09 ET
|
Stem Cell Network
OTTAWA, March 31, 2020 (GLOBE NEWSWIRE) -- In recent weeks, a number of claims have been made that stem cells can be used as a treatment for the coronavirus disease (COVID-19). Globally, there is no...
BrainStorm Cell Therapeutics and FDA Agree to Potential NurOwn® Regulatory Pathway for Approval in ALS
February 11, 2020 06:00 ET
|
BrainStorm Cell Therapeutics Inc.
NEW YORK, Feb. 11, 2020 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics, Inc., (NASDAQ:BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced that...
Esperite N.V.: Samples and Database are safe. The recent articles published about CryoSave on loss of samples are poorly informed and defamatory.
February 10, 2020 01:17 ET
|
Esperite N.V.
Samples and Database are safe Amsterdam, The Netherlands – 10 February 2020 Esperite N.V. (Euronext: ESP, “Esperite”) has noticed several articles in the news, online channels and information blogs...
UK Regulatory Authority Approves Cynata’s Phase 2 Clinical Trial in Critical Limb Ischaemia
January 14, 2020 08:05 ET
|
Cynata Therapeutics Limited
MELBOURNE, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that it has...
REGENERATIVE MEDICINE FOUNDATION’S BOARD OF DIRECTORS EMBRACES NEW MEMBERS AND VISIONARY LEADERSHIP
January 03, 2020 09:08 ET
|
Regenerative Medicine Foundation
Washington, DC - (January 2, 2020), Jan. 03, 2020 (GLOBE NEWSWIRE) -- The Regenerative Medicine Foundation (RMF), a not-for-profit organization dedicated tothe advancement of ethical research and...
BrainStorm Selected as Buzz of BIO 2020 Winner
December 11, 2019 05:00 ET
|
BrainStorm Cell Therapeutics Inc.
NEW YORK, Dec. 11, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in the development of innovative autologous cellular therapies for highly debilitating...
BrainStorm Announces the Mount Sinai Medical Center as a Progressive MS Phase 2 Clinical Trial Site
November 25, 2019 06:00 ET
|
BrainStorm Cell Therapeutics Inc.
NEW YORK, Nov. 25, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating...
BrainStorm Cell Therapeutics Announces Publication of NurOwn® ALS Phase 2 Randomized Clinical Trial Data in Neurology
November 20, 2019 07:00 ET
|
BrainStorm Cell Therapeutics Inc.
A single transplantation of MSC-NTF cells (NurOwn®) in ALS clinical trial participants met the primary safety endpoint and demonstrated promising stabilization of ALS disease progression of up to...